ditamin 2,5 mg tablete
lek d.d. - dihidroergotamin - tableta - dihidroergotamin 2,15 mg / 1 tableta - dihidroergotamin
epikutani test monoetanolamin allergeaze 2 % mazilo
iris d.o.o. - monoetanolamin - mazilo - monoetanolamin 2 % / 1 ml - alergijski testi
eloxatin 5 mg/ml koncentrat za raztopino za infundiranje
sanofi-aventis d.o.o. - oksaliplatin - koncentrat za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin
eloxatin 5 mg/ml koncentrat za raztopino za infundiranje
sanofi-aventis d.o.o. - oksaliplatin - koncentrat za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin
eloxatin 5 mg/ml koncentrat za raztopino za infundiranje
sanofi-aventis d.o.o. - oksaliplatin - koncentrat za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin
eloxatin 5 mg/ml prašek za raztopino za infundiranje
sanofi-aventis d.o.o. - oksaliplatin - prašek za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin
eloxatin 5 mg/ml prašek za raztopino za infundiranje
sanofi-aventis d.o.o. - oksaliplatin - prašek za raztopino za infundiranje - oksaliplatin 5 mg / 1 ml - oksaliplatin
fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
ceplene
laboratoires delbert - histamin dihydrochloride - leukemija, myeloid, akutna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). učinkovitost zdravila ceplene ni bila v celoti dokazana pri bolnikih, starejših od 60 let.
scemblix
novartis europharm limited - asciminib hydrochloride - levkemija, mielogena, kronična, bcr-abl pozitivna - antineoplastična sredstva - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.